Pricing Log in Create free account

ANIXA BIOSCIENCES INC (ANIX) vs NovaBridge Biosciences (NBP)

ANIXA BIOSCIENCES INC and NovaBridge Biosciences are both Biotechnology companies. ANIXA BIOSCIENCES INC and NovaBridge Biosciences are of similar size ($105.3M and $105.3M). ANIXA BIOSCIENCES INC grew revenue faster over the last twelve months: −34.1% against −91.8%. Across the 13 metrics below, ANIXA BIOSCIENCES INC leads on 7 and NovaBridge Biosciences on 6.

Valuation

Metric ANIX NBP Biotechnology median
P/E n/m n/m 10.60
P/S 111.13 3.79 9.40
P/B 8.18 0.37 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 2.71 0.66
EV/Sales 100.73 (5.33) 9.02
Earnings yield (10.13%) (54.06%) (32.88%)
Free cash flow yield (6.80%) (125.76%) (23.13%)

Profitability

Metric ANIX NBP Biotechnology median
Gross margin 0.00% 31.10% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (72.57%) 0.00% (51.96%)
Return on assets (63.45%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANIX NBP Biotechnology median
Revenue growth (TTM) (34.10%) (91.84%) 6.76%
EPS growth (last fiscal year) 12.82% (77.78%) 29.88%
Revenue growth, 5-year CAGR (6.89%) (40.00%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANIX NBP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.55 7.64 4.97
Net debt to EBITDA 1.29 2.26 1.01

Dividend

Metric ANIX NBP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ANIX NBP Biotechnology median
Market cap 105.34m 105.34m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack